A phase I study of HER1, HER2 dual kinase inhibitor lapatinib plus the proteasome inhibitor bortezomib in patients with advanced malignancies
Titel:
A phase I study of HER1, HER2 dual kinase inhibitor lapatinib plus the proteasome inhibitor bortezomib in patients with advanced malignancies
Auteur:
Lynce, Filipa Wang, Hongkun Petricoin, Emanuel F. Pohlmann, Paula R. Smaglo, Brandon Hwang, Jimmy He, Aiwu R. Subramaniam, Deepa S. Deeken, John Marshall, John Pishvaian, Michael J.